After losing their sons to drug overdoses, two Orange County mothers set out to educate young people about prescription drugs, addiction, and overdose. Through firsthand accounts from grieving parents, young people affected by addiction, and addiction professionals, this documentary explores how experimentation can develop into devastating substance use problems. Created as a prevention tool for young audiences and families, it challenges assumptions about who can develop an addiction while emphasizing the consequences of drug use, the warning signs families should recognize, and the importance of honest conversations.
As prescription drug misuse grew across Tennessee, communities began confronting doctor shopping, medication diversion, overdose, and increasing access to controlled substances. This documentary examines an early response to what would later become a nationwide opioid crisis, bringing together perspectives from law enforcement, healthcare professionals, pharmacists, coalition leaders, and people directly affected. It explores prescription monitoring, youth prevention, community partnerships, and the challenges of distinguishing legitimate pain treatment from problematic drug use while capturing the warning signs of a rapidly developing public health crisis.
Prescription opioid dependence can affect people of all ages and backgrounds, including those who first encounter opioids through legitimate pain treatment. Focusing on communities in Ontario, this documentary combines personal experiences with perspectives from healthcare professionals, treatment providers, and community leaders. It examines opioid withdrawal, stigma, harm reduction, methadone treatment, counselling, and other approaches to recovery while exploring the challenges of balancing pain management with the risks of prescription opioids and responding to addiction as a public health issue.
This 2012 Global News investigation examines the OxyContin controversy in Canada through the experiences of patients, grieving families, researchers, and medical professionals. As prescriptions for the powerful pain medication increased, so did concerns about addiction, overdose, and the way its risks had been presented to doctors and patients. The report investigates Purdue Pharma's marketing of OxyContin, its influence within pain medicine, and allegations that the drug's potential for addiction was deliberately downplayed, while revealing the devastating consequences prescription opioid use had already left behind.
Across Arkansas, individuals and families share deeply personal experiences of opioid addiction, overdose, loss, and recovery. Their stories reveal how prescription opioids, heroin, and fentanyl have shaped the state's opioid crisis, while experts explain how dependence and opioid use disorder can develop and why the drug supply has become increasingly dangerous. Alongside accounts of repeated overdose and lives lost are stories of survival and recovery, highlighting the work of healthcare professionals, advocates, families, and communities responding to the crisis and supporting people as they rebuild their lives.
Families, harm-reduction workers, and experts share their experiences of North Carolina’s fentanyl epidemic and the devastating toll of overdose across the state. The documentary examines how the opioid crisis evolved from prescription medications to heroin and illicit fentanyl, while exploring drug trafficking, pharmaceutical accountability, and the state’s response to rising deaths. It also looks at harm-reduction efforts, including naloxone and fentanyl test strips, and follows people working directly with communities affected by addiction. Their stories show both the human cost of the crisis and the efforts underway to prevent further loss.
Through personal stories and community perspectives, the film examines the stigma surrounding addiction and the damage caused by shame, judgment, and misunderstanding. People in recovery, health-care professionals, law enforcement, and advocates discuss prescription opioids, heroin, overdose, and the barriers that can prevent people from seeking treatment. It also explores decriminalization and different approaches to recovery while challenging the idea that addiction is simply an individual problem, asking communities to reconsider how people with substance use disorders are treated and what meaningful support should look like.
After years of reporting on addiction and the opioid crisis, journalist Angela Kennecke experienced the crisis personally when her 21-year-old daughter, Emily, died from fentanyl poisoning. She shares her family’s story while continuing to investigate the issues affecting other families across South Dakota. Through personal stories and expert perspectives, the special explores fentanyl, overdose, stigma, Good Samaritan laws, drug courts, medication-assisted treatment, and recovery. It also follows Kennecke as she turns the loss of her daughter into advocacy through Emily’s Hope, an organization dedicated to prevention, awareness, and recovery.
Personal stories of prescription opioid and heroin addiction reveal how quickly substance use can take over a person’s life and affect everyone around them. Individuals and families share experiences of withdrawal, relapse, overdose, grief, and recovery, while professionals discuss the progression of opioid addiction and the risks facing young people. Several stories trace the transition from prescription painkillers to heroin, showing how tolerance, dependence, cost, and the pursuit of a stronger high can lead people down increasingly dangerous paths.
Families, frontline workers, advocates, and experts share their experiences of Canada’s opioid crisis and the failures that have allowed it to continue. Their stories examine prescription opioid addiction, stigma, drug policy, and the enormous toll of overdose on families and communities. The film also looks at harm reduction and decriminalization, questioning decades of punitive approaches to drug use while highlighting the people and organizations pushing for a public health response that focuses on keeping people alive.
